About this episode
Today’s guest, Peter Koshland, PharmD, opened his compounding pharmacy, Koshland Pharm, in 2009 in San Francisco and works with doctors and patients on individualized, integrative therapies that make a difference in the quality of patients’ day-to-day lives. Peter has seen the profound impact high-quality compounded medicine can have, so producing the absolute best patient outcomes is what drives his decisions as CEO of Koshland Pharm. When he is not in the pharmacy, Peter spends his time consulting with and educating doctors about the multiple applications of compounded medicine in their respective fields. Interview topics: Compounding for hormone replacement, dermatology, urology, thyroid disorders, and pain management Why big pharma is lobbying against bio-identical HRT How bias against compounding pharmacies could limit the options available to doctors treating patients The economic impact that FDA overreach could have on pharmacists across the country The importance of custom tailoring hormone treatments instead of using a “one size fits all” approach Learn more about your ad choices. Visit megaphone.fm/adchoices